After 23 goals and 24 assists in 142 appearances across all competitions for Bayer Leverkusen during a four year spell, Amine ...

Under the global exclusive license deal, Kumquat will be responsible for the Phase 1a study of its inhibitor and Bayer will ...

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...

BERLIN (Reuters) -German pharmaceutical group Bayer announced on Tuesday a deal worth up to $1.3 billion with Kumquat ...

Bayer Leverkusen have announced the signing of Ernest Poku (21) from AZ Alkmaar for a reported €12m including bonuses. The ...

After securing Ernest Poku’s transfer, Bayer Leverkusen are continuously looking to strengthen their squad for the 2025/26 ...

Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.

Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...

For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

An announcement from Board of Education President Steven Blair on Friday said Mike Dominguez resigned July 31 to "pursue ...